PARVOVIRUS B 19 - ANVISA Registration 10259610241

Access comprehensive regulatory information for PARVOVIRUS B 19 in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10259610241 and manufactured by VIRCELL S.L.. The registration is held by MEDIVAX INDÚSTRIA E COMÉRCIO LTDA with validity until Oct 15, 2028.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including DIASORIN ITALIA S.P.A., DIASORIN MOLECULAR LLC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.